Skip to main content

Find Clinical Trials

Home
Conditions
Angiogenesis Inhibition in Oncology

Clinical trial condition

Angiogenesis Inhibition in Oncology

Explore clinical trials studying Angiogenesis Inhibition in Oncology. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Angiogenesis Inhibition in Oncology trial results

Recruiting

Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study

NCT06728852

Conditions: Advanced Non-small Cell Lung Cancer (NSCLC), Angiogenesis Inhibition in Oncology, Disease Attributes, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details